Joined
·
13,221 Posts
Movetis, a European pharmaceutical company focused on the discovery, development and commercialisation of innovative drugs for the treatment of diseases in the GI area, announces that it has launched its lead product, Resolor® (prucalopride) in Germany. As of today, pharmacists in Germany can dispense Resolor to patients who have received a medical prescription for this medicine. http://www.movetis.com/journalists/press-r...urce=journalist
